QNRX
Quoin Pharmaceuticals, Ltd.Company Information
- Company Name
- Quoin Pharmaceuticals, Ltd.
- CIK
- CIK0001671502
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- QNRX: Nasdaq
- Fiscal Year End
- N/A
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- QNRX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-31
- Last sale
- 2024-06-07
- Shares purchased (TTM)
- 72,522
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1
- Shares outstanding
- 80,940
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 42.63%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 3 | 4 | 2 | 2 | 4 | 4 | 3 | 3 | 2 | 2 | 3 | ||||||
| Short Term Investments | 7 | 11 | 15 | 4 | 6 | 8 | 10 | 7 | 10 | 13 | 8 | 11 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | - | ||||||
| Assets Current | 12 | 15 | 20 | 6 | 8 | 12 | 15 | 10 | 13 | 15 | 11 | 14 | ||||||
| Prepaid Expense Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets | 12 | 16 | 20 | 6 | 9 | 13 | 16 | 11 | 14 | 16 | 12 | 15 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | ||||||
| Accrued Liabilities Current | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 3 | ||||||
| Interest Payable Current And Noncurrent | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Interest Payable Current | 1 | 1 | 1 | - | - | - | 1 | - | - | - | - | - | ||||||
| Other Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 7 | 5 | 6 | 6 | 4 | 5 | 4 | 3 | 4 | 4 | 4 | 5 | ||||||
| Other Liabilities Noncurrent | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | ||||||
| Liabilities | 8 | 7 | 7 | 8 | 6 | 7 | 7 | 6 | 7 | 7 | 7 | 8 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Value | - | - | - | - | - | - | - | - | - | - | - | -3 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | - | - | - | - | - | - | - | - | - | ||||||
| Additional Paid In Capital | 85 | 85 | 84 | 65 | 65 | 65 | 64 | 58 | 58 | 58 | 52 | 54 | ||||||
| Retained Earnings Accumulated Deficit | -81 | -76 | -71 | -67 | -63 | -59 | -55 | -53 | -51 | -49 | -46 | -44 | ||||||
| Stockholders Equity | 4 | 9 | 13 | -1 | 3 | 6 | 9 | 5 | 7 | 9 | 6 | 7 | ||||||
| Liabilities And Stockholders Equity | 12 | 16 | 20 | 6 | 9 | 13 | 16 | 11 | 14 | 16 | 12 | 15 | ||||||
| Adr | 0 | 2 | 0 | -0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 143 | 143 | 143 | 143 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | ||||||
| Common Stock Shares Issued | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Shares Acquired | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialQuoin Pharmaceuticals, Ltd. (QNRX) — SEC Financial Statements & Analysis
Quoin Pharmaceuticals, Ltd. (QNRX) is a pharmaceutical preparations company, incorporated in L3. Quoin Pharmaceuticals, Ltd. trades on Nasdaq as: QNRX. Quoin Pharmaceuticals, Ltd. (QNRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Quoin Pharmaceuticals, Ltd. carries a market cap of $391.75K, a P/E ratio of -0.02x, a P/B ratio of 0.10x, an enterprise value of $-3.45M, and an EV/EBITDA multiple of 0.19x. On profitability, it posts a Return on Equity (ROE) of -575.73%, a Return on Assets (ROA) of -178.77%, and a Return on Invested Capital (ROIC) of -3848.80%. Per share, it reports EPS of $-230.61, diluted EPS of $-230.61, free cash flow per share of $-188.70, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 53.38% year-over-year and EPS growth of -68.16% year-over-year. On the balance sheet, it maintains a current ratio of 1.76x, a quick ratio of 1.63x, working capital of $5.02M, a debt-to-equity ratio of 2.04x, a debt ratio of 0.67, free cash flow of $-15.27M (TTM), and net debt of $-3.85M. Figures sourced from SEC EDGAR.
- Market Cap
- $391.75K
- P/E TTM
- -0.02x
- EPS TTM
- $-230.61
- P/B TTM
- 0.10x
- ROE TTM
- -575.73%
- ROA TTM
- -178.77%
- Debt To Equity
- 2.04x
- Free Cash Flow TTM
- $-15.27M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Quoin Pharmaceuticals, Ltd. in?
Quoin Pharmaceuticals, Ltd. (QNRX) operates in the Pharmaceutical Preparations industry.
What exchange does QNRX trade on?
Quoin Pharmaceuticals, Ltd. (QNRX) trades on the Nasdaq.
Where is Quoin Pharmaceuticals, Ltd. incorporated?
Quoin Pharmaceuticals, Ltd. is incorporated in Israel.
When was Quoin Pharmaceuticals, Ltd. (QNRX)'s most recent SEC filing?
Quoin Pharmaceuticals, Ltd. (QNRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is QNRX's market cap?
Quoin Pharmaceuticals, Ltd. (QNRX) has a market capitalization of $391.75K as of 2026-06-30.
What is QNRX's EPS (earnings per share)?
Quoin Pharmaceuticals, Ltd. (QNRX)'s trailing twelve month EPS is $-230.61 as of 2026-06-30.
What is QNRX's ROE (return on equity)?
Quoin Pharmaceuticals, Ltd. (QNRX)'s trailing twelve month Return on Equity (ROE) is -575.73% as of 2026-06-30.
What is QNRX's ROA (return on assets)?
Quoin Pharmaceuticals, Ltd. (QNRX)'s trailing twelve month Return on Assets (ROA) is -178.77% as of 2026-06-30.
What is QNRX's ROIC (return on invested capital)?
Quoin Pharmaceuticals, Ltd. (QNRX)'s trailing twelve month Return on Invested Capital (ROIC) is -3848.80% as of 2026-06-30.
What is QNRX's EV/EBITDA?
Quoin Pharmaceuticals, Ltd. (QNRX)'s trailing twelve month EV/EBITDA is 0.19x as of 2026-06-30.